spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  premature ejaculation 

 HSMN NewsFeed - 8 Nov 2016
Innovus Pharma Signs Exclusive License and Distribution Agreement with Elis Pharmaceuticals for Zestra(R) in Lebanon
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 22 Sep 2014
Innovus Pharma Signs License Agreement With Orimed Pharma for Zestra(R), EjectDelay(TM), Sensum+(TM) and Zestra Glide(R) in Canada
Biopharmaceuticals Licensing
 HSMN NewsFeed - 15 Aug 2014
Innovus Pharma and Consortia Health Initiate a Nationwide Marketing and Sales Campaign to U.S. Gynecologists for Zestra(R), Clinically Proven for the Enhancement of Female Arousal Desire and Satisfaction
Biopharmaceuticals
 HSMN NewsFeed - 11 Feb 2014
Innovus Pharma Expands Management Team and Adds Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jul 2013
VIVUS Announces Avanafil Partnership With Menarini
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 Jan 2013
Absorption Pharmaceuticals Names Laurence A. Levine, MD As The Company's Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2012
Ampio Reports Successful Type B Pre-IND Meeting with the FDA for its Drug Zertane(TM) to treat Premature Ejaculation (PE)
Biopharmaceuticals Urology FDA
 HSMN NewsFeed - 5 Dec 2011
Ampio Pharmaceuticals Announces Agreement to Acquire Key Drug Delivery Technology
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 27 Jul 2010
Ampio Pharmaceuticals, Inc. Announces Acquisition of DMI BioSciences, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Apr 2010
Ampio Pharmaceuticals to Acquire DMI Biosciences, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Jul 2009
Sciele Pharma and Plethora Solutions Announce Positive Results of Final Phase III Pivotal Trial for PSD502 for Premature Ejaculation
Biopharmaceuticals
 HSMN NewsFeed - 24 May 2007
Sciele Enters Into Exclusive License Agreement with Plethora Solutions Limited to Market PSD502 for the Treatment of Premature Ejaculation
Biopharmaceuticals Licensing
 HSMN NewsFeed - 26 Sep 2006
Indevus Announces Clinical and Regulatory Plans for Pagoclone
Biopharmaceuticals
 HSMN NewsFeed - 7 Jul 2006
Indevus Announces Positive Data from Second Phase III Trial for SANCTURA XR(TM) in Overactive Bladder
Biopharmaceuticals
 HSMN NewsFeed - 26 Jun 2006
NexMed Announces Termination of Alprox-TD Agreement With Schering AG and Provides Operational Update
Biopharmaceuticals Drug Delivery Licensing Distribution
Return to NewsFeed  

 Additional items found! 9

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 9 additional stories matching:
premature ejaculation
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.